CVS Health (CVS) – Research Analysts’ Recent Ratings Changes

Several brokerages have updated their recommendations and price targets on shares of CVS Health (NYSE: CVS) in the last few weeks:

• 7/20/2026 – CVS Health was upgraded by Weiss Ratings from “hold (c)” to “hold (c+)”.
• 7/15/2026 – CVS Health was downgraded by Wall Street Zen from “buy” to “hold”.
• 7/14/2026 – CVS Health had its price target raised by Truist Financial Corporation from $108.00 to $118.00. They now have a “buy” rating on the stock.
• 7/13/2026 – CVS Health had its price target raised by Wells Fargo & Company from $103.00 to $123.00. They now have an “overweight” rating on the stock.
• 7/9/2026 – CVS Health had its price target raised by Royal Bank Of Canada from $107.00 to $113.00. They now have an “outperform” rating on the stock.
• 7/7/2026 – CVS Health was upgraded by Wall Street Zen from “hold” to “buy”.
• 7/7/2026 – CVS Health had its price target raised by Cantor Fitzgerald from $100.00 to $110.00. They now have an “overweight” rating on the stock.
• 7/6/2026 – CVS Health had its “hold” rating reaffirmed by HSBC Holdings plc. They now have a $103.00 price target on the stock.
• 6/29/2026 – CVS Health was downgraded by Wall Street Zen from “buy” to “hold”.
• 6/22/2026 – CVS Health had its price target raised by Bank of America Corporation from $100.00 to $110.00. They now have a “buy” rating on the stock.
• 6/21/2026 – CVS Health was upgraded by Wall Street Zen from “hold” to “buy”.
• 6/13/2026 – CVS Health was downgraded by Wall Street Zen from “buy” to “hold”.
• 6/11/2026 – CVS Health had its “overweight” rating reaffirmed by Cantor Fitzgerald.
• 6/8/2026 – CVS Health had its price target raised by Mizuho from $110.00 to $115.00. They now have an “outperform” rating on the stock.
• 6/8/2026 – CVS Health had its price target raised by UBS Group AG from $100.00 to $115.00. They now have a “buy” rating on the stock.
• 6/4/2026 – CVS Health had its price target raised by Morgan Stanley from $106.00 to $111.00. They now have an “overweight” rating on the stock.
• 6/1/2026 – CVS Health had its “overweight” rating reaffirmed by Piper Sandler. They now have a $113.00 price target on the stock.
• 6/1/2026 – CVS Health had its price target raised by Truist Financial Corporation from $102.00 to $108.00. They now have a “buy” rating on the stock.
• 5/26/2026 – CVS Health had its price target raised by Barclays PLC from $101.00 to $106.00. They now have an “overweight” rating on the stock.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd will be given a dividend of $0.665 per share. The ex-dividend date is Thursday, July 23rd. This represents a $2.66 annualized dividend and a yield of 2.5%. CVS Health’s payout ratio is presently 117.18%.

Insider Activity at CVS Health

In other news, EVP Tilak Mandadi sold 69,551 shares of CVS Health stock in a transaction on Friday, May 8th. The shares were sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the completion of the sale, the executive vice president directly owned 10,133 shares of the company’s stock, valued at approximately $907,714.14. The trade was a 87.28% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Larry Robbins sold 370,462 shares of the company’s stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $93.45, for a total transaction of $34,619,673.90. Following the completion of the transaction, the director owned 4,824,799 shares of the company’s stock, valued at $450,877,466.55. This trade represents a 7.13% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 3,441,551 shares of company stock valued at $323,703,977. 0.85% of the stock is currently owned by company insiders.

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.